Publications by the researcher in collaboration with PEDRO PEREZ SEGURA (13)

2023

  1. Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer

    Oncology Letters, Vol. 25, Núm. 1

2022

  1. Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy

    Frontiers in Oncology, Vol. 12

2021

  1. Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer

    Oral Oncology

  2. Tumor cerebral de alto grado versus accidente cerebrovascular. Utilidad del corregistro de PET y RM

    Anales de la Real Academia Nacional de Medicina, Núm. 138, pp. 176-179

  3. Safety and Efficacy of Cetuximab-Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck Cancer

    Oncologist, Vol. 26, Núm. 6, pp. e1018-e1035

  4. Major and durable response to second-line pembrolizumab-carboplatin-paclitaxel in an oral cavity cancer patient

    Anti-Cancer Drugs, Vol. 32, Núm. 5, pp. 580-584

  5. Development of the Anxiety, Depression and Coping (ADAF) screening tool for emotional and coping problems in cancer patients

    Psycho-Oncology, Vol. 30, Núm. 11, pp. 1894-1901

2020

  1. Increased clinical and plasma EBV DNA responses to platinum-gemcitabine after nivolumab in patients with heavily platinum-pretreated nasopharyngeal cancer

    Oral Oncology

2019

  1. Response to immunotherapy rechallenge after interval chemotherapy in a patient with head and neck cancer

    Anti-Cancer Drugs, Vol. 30, Núm. 2, pp. 149-152

  2. Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy

    Oncologist, Vol. 24, Núm. 3, pp. 293-300

  3. Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer

    Head and Neck, Vol. 41, Núm. 6, pp. E86-E92

2007

  1. Tratamiento de los astrocitomas de alto grado: Papel de la radioquimioterapia

    Revisiones en Cancer, Vol. 21, Núm. 1, pp. 13-21

1996

  1. COMPARACION DE LA GAMMAGRAFIA OSEA Y LA PET 18FDG EN UN CASO DE MAMA METASTASICO

    Revista Espanola de Medicina Nuclear